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Abstract
Introduction. Hepatocellular carcinoma (HCC) is the most fre-
quent primary malignant tumor of the liver. It is usually seen in
the 6th and 7th decades of life and chronic hepatitis B is the
most frequent cause. Extrahepatic metastasis of HCC is an indi-
cator of a poor prognosis and the most common sites are lungs,
bones, lymph nodes, kidneys and adrenal glands. We reported a
case of isolated metastasis in the right maxilla, which had been
found initially, before the tumor in the liver was diagnosed. Case
report. A 70-year-old man underwent dental surgery of the up-
per right molar. Prolonged bleeding control was difficult for up
to two weeks, so the biopsy was performed. Histopathological
analysis revealed a metastatic hepatocellular carcinoma. Comput-
erized tomography (CT) of the abdomen revealed a diffusely
heterogeneous liver parenchyma with irregular borders and two
foci of mass lesions. There were metastasis in the spleen and also
two pathological retroperitoneal lymph nodes were detected, but
no ascit, liver cirrhosis, cholestasis or portal vein thrombosis
were seen. CT of the orbital and maxillary regions revealed a tu-
mor mass in the right maxillary sinus, spreading to the alveolar
sinus, nasal cavity and partially infratemporal space. A tumor
mass was in the right orbit as well, infiltrating the surrounding
bones and muscles. Clinically, there was proptosis of the right
eye accompanied by amaurosis. The treatment started with che-
motherapy based on 5-fluorouracil (sorafenib was not available).
After three cycles, control CTs showed a stable disease in the
liver, but progression in the right maxillary sinus and orbit. Enu-
cleation of the right eye was performed and postoperative ra-
diotherapy was planed. The patient deteriorated rapidly and died,
about 6 months after the disease had been diagnosed. Conclu-
sion. Extrahepatic metastasis of HCC represents a progressive
phase of the disease with poor prognosis, so the main aim of the
treatment should be palliation and care of symptoms.
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Apstrakt
Uvod. Hepatocelularni karcinom (hepatocellular carcinoma – HCC)
predstavlja najčešći primarni maligni tumor jetre koji ima agresivan
tok sa preživljavanjem od svega nekoliko meseci. Kod oko 80%
bolesnika glavni uzročnik HCC je ciroza jetre u kombinaciji sa
hroničnim virusnim hepatitisom, pretežno tipa B i C. Prisustvo ek-
strahepatičkih metastaza je indikator loše prognoze. Metastaze se
najčešće javljaju u plućima, kostima, limfnim čvorovima, bubrezi-
ma i nadbubrežnim žlezdama. Predstavili smo bolesnika sa metas-
tazom hepatocelularnog karcinoma u gornjoj vilici i očnoj duplji.
Prikaz bolesnika. Bolesnik, star 70 godina, bio je podvrgnut eks-
trakciji gornjih desnih kutnjaka. Nakon ekstrakcije nastalo je krva-
renje koje nije moglo da se zaustavi tokom dve nedelje. Urađena je
biopsija okolnog tkiva, a patohistološka dijagnoza potvrdila je da se
radi o metastazi hepatocelularnog karcinoma. Na kompjuterizova-
noj tomografiji abdomena viđene su hipodenzne fokalne promene
u jetri i slezini kao i izmenjeni limfni čvorovi u retroperitonealnom
prostoru paraaortalno. Kompjuterizovana tomografija srednjeg
masiva lica pokazala je tumor koji u potpunosti ispunjava desni
maksilarni sinus, razara alveolarni produžetak i širi se u nosnu šup-
ljinu i infratemporalni prostor. U desnoj očnoj duplji tumor se u
potpunosti infiltrisao u spoljašnji pravi mišić pokretač očne jabuči-
ce i razarao je spoljašnji zid orbite. Kliničkim pregledom registro-
vana je protruzija desne očne jabučice. Lečenje je započeto prvom
linijom sistemske hemoterapije baziranoj 5-fluorouracila. Nakon tri
ciklusa registrovana je stabilizacija bolesti u jetri, ali i dalja progre-
sija u gornjoj vilici i očnoj duplji. Učinjena je enukleacija desnog
oka. Planirana zračna terapija predela maksilarnog sinusa i orbite
desno nije sprovedena, s obzirom na to da je bolesnik egzitirao.
Zaključak. Ekstrahepatične metastaze hepatocelularnog karcino-
ma predstavljaju odmaklu fazu bolesti i indikator su loše prognoze.
Iz tih razloga, glavni cilj terapije treba da bude usmeren ka palijati-
vnom lečenju i zbrinjavanju simptoma bolesti.
Ključne reči:
hepatom; neoplazme, metastaze; vilice; orbita;
dijagnoza; lečenje, ishod.Strana 360 VOJNOSANITETSKI PREGLED Volumen 68, Broj 4
Kolarević D, et al. Vojnosanit Pregl 2011; 68(4): 359–362.
Introduction
Metastatic hepatocellular carcinoma (HCC) is a very
aggressive disease with poor prognosis and only a few
months’ survival 
1. It is the most common primary liver can-
cer 
2. It is usually seen in the sixth and seventh decade of life.
About 80% of HCC is caused by cirrhosis combined with
chronic viral hepatitis B or C 
3–5. Second cause of HCC is al-
coholism, with or without viral infection presence 
6. At the
moment of diagnosis, about 50% of patients have distant
metastases, while the occurrence of extrahepatic metastases
indicates a bad prognosis 
7. Most common metastatic sites
are lungs, bones, lymph nodes, kidneys and adrenal glands 
4,
5, 8–10. Rarely, HCC can be manifested as metastatic deposits
without primary tumor in liver 
11, 12. Unlike HCC metastases
in the upper jaw which are described more often in the lit-
erature 
13–17, the metastases to the maxilla have been seen
only in one case 
18.
In this paper we presented the patient with hepatocel-
lular carcinoma metastases in the upper jaw and maxillary
sinus additionally spreaded to the orbit. It manifested as a
prolonged bleeding after tooth extraction.
Case report
A 70-year-old patient underwent surgical removal of
upper molars. Two weeks later, biopsy of surrounding tissue
due to prolonged bleeding after the applied haemostasis, was
performed. Routine histopathological analysis showed ma-
lignant metastatic tumor, most probably hepatocellular or re-
nal carcinoma metastasis (Figure 1). In order to reveal the
metastasis origin, we used additional immunohistochemical
staining: HepPar (OCH1E5, 1:25), Vimentin (V9, 1:200),
TTF-1 (8G7G3/1, 1:10), CK7 (OV-TL12/30, 1:50), CK20
(Ks20.8, 1:50), made by DAKO and RCC (66.4C2, 1:50)
made by Novocastra lab. LSAB+system visualisation. Tumor
cells manifested strong immunoreactive staining for HepPar
antibody (Figure 2) known as one of the most specific and
most sensitive markers for HCC 
19. Cells did not show any
immunoreactivity for the other used antibodies: vimentin,
TTF-1, CK7, CK20 and RCC antibody.
Fig. 2 – Tumor cells reveal diffuse granular staining of
cytoplasm (HE ×100)
Abdomen CT showed two hypodense focal changes in
the liver (segment VIII), dimensions 22 mm and 30 mm. One
hypodense focal change was seen in the spleen, 22  mm di-
ameter, as well as two soft-tissue formations around the
aorta, interpreted as abnormal lymph nodes, dimension 21
mm and 44 mm. Nodular formations up to 11 mm were seen
in the mesenterium.
CT of the orbital and maxillary regions revealed a tu-
mor mass in the right maxillary sinus, spreading to the al-
veolar sinus, nasal cavity and partially in the infratemporal
space. The tumor mass was also disseminated in the right or-
bit, infiltrating the surrounding bones and muscles.
Radiography of the lungs and skeletal system was nor-
mal.
Laboratory findings before the treatment were: urea 9.0
mmol/L; creatinine 122 μmol/L; total bilirubin 35.4 μmol/L;
aspartat-aminotranspherase (AST) 86 UI/L; alanin-
aminotranspherase (ALT) 106 UI/L; alkaline-phosphatase
(ALP) 295 UI/L. Alpha-fetoprotein (AFP) was 18309
ng/mL. In blood count, a mild anemia was detected, with
hemoglobin level of 102 g/L. All other parameters were
within normal ranges.
Clinically, there was proptosis of the right eye, wors-
ening over time, accompanied by amaurosis and a complete
loss of vision in the right eye after two months (Figure 3).
The patient had a strong pain in the right side of the head,
managed by opioid painkillers.
Cirrhosis of the liver and viral hepatitis infection B
were not confirmed. The patient was a non-smoker and did
not consume alcohol.
Karnofsky Performance Status before the treatment was
80%, but gradually decreased to 60%.
According to the multidisciplinary team (MDT) deci-
sion, the treatment started with the first line of systemic
chemotherapy based on 5-fluorouracil and leucovorin.
Sorafenib was not available. Three cycles were applied,
every 28 days. During the chemotherapy, hemoglobin levels
Fig. 1 – Tumor composed of solid sheats of large cells
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were gradually decreasing to 88, 76 and 64 g/L, which re-
quired blood transfusion several times. After three cycles of
chemotherapy, MDT did the evaluation of disease progress.
Control CTs showed a stable disease in the liver, but appar-
ent progression in the right maxillary sinus and orbit. Finding
in the right eye was also worse with gradual loss of vision.
Pain was more intensive and not manageable with morphine
analgesics.
The patient was presented to MDT, who indicated enu-
cleation of unfunctional eye with additional radiotherapy of
maxillary sinus and right orbit. He was hospitalized in the
Clinic for Eye Disease where the planned operation was per-
formed, without any postoperative complications. Histopa-
thology of the enucleated right bulbus revealed deformity
caused by spontaneous rupture but no elements of tumor
were found. Although all symptomatic therapy was given,
the patient’s condition was getting worse. Radiotherapy was
not performed. The patient died six months after the diag-
nose had been settled.
Discussion
Hepatocellular carcinoma is a very aggressive disease
with a five-year survival in 0.8% men and 4.4% women 
20.
Intrahepatic metastases appear very early and more than
50% of patients have extrahepatic metastases as well 
18. A
role in metastases development can be recognized in the
state of liver parenchyma and the level of liver damage
caused by viral hepatitis 
21. Metastases are usually spread
by intrahepatic blood and lymphatic vessels or by direct in-
filtration. Hematogenic spreading means spreading through
the hepatic portal vein or vena cava. The most common
metastatic sites are: lungs (18.1%–49.2%), lymph nodes
(26.5%–41.7%), bones (4.2%–16.3%) and adrenal glands
(8.4%–15.4%) 
4, 5, 8–10.
Treatment of patients with hepatocellular carcinoma
depends mostly on the disease stage. When the disease is
localized to the liver only, the main therapy option is sur-
gical removal of the tumor. In the locally advanced and
metastatic disease, the only choice is systemic chemother-
apy. So far, there have been no precise protocols for pa-
tients with extrahepatic metastases, but the usage of cyto-
statics is very often limited by a bad performance status of
a patient 
22.
The patient presented in this paper had metastases in
the maxillary sinus spreading to the orbit and nasal cavity.
Metastases were also detected in the spleen and paraaortal
lymph nodes. Liver cirrhosis and viral hepatitis infection B
were not confirmed. Levels of bilirubin, transaminases and
alkaline-phosphatase were doubled, while alpha-fetoprotein
level was 18.000. The disease was manifested in a meta-
static phase so chemotherapy was the treatment of choice.
Three cycles of chemotherapy based on 5-fluorouracil were
administrated with a final effect of disease progression.
Due to spontaneous cornea perforation caused by lag-
ophtalmus and tumor compression, the right bulbar enu-
cleation was performed. Palliative radiotherapy of the
maxillary sinus and right orbit was not completed because
the patient died. He lived six months after the moment of
diagnosis.
While metastases of hepatocellular carcinoma to the
mandible have been described in many papers 
13–17, metasta-
ses in the maxilla are very rare 
18. Clinical and autopsy find-
ings of these cases revealed two ways of metastatic spread-
ing to the maxillary-facial region. When cancer cells reach
the hepatic artery and portal vein, the first metastatic site are
lungs. From the lungs, dissemination goes to the maxillary
area 
18. In other case, if autopsy does not show any metasta-
ses in lungs, dissemination to maxillary area is considered to
be either by vertebral and azygos vein system or by lym-
phatic system.
The presented patient had no confirmed lung metasta-
ses, which suggested that spreading of cancer cells to the
maxillary sinus and the orbit had been by lymphatic or verte-
bral vein system.
The presence of extrahepatic metastases is an indicator
of bad prognosis. In that stage the only treatment is chemo-
therapy. Due to very aggressive nature of disease with rapid
deterioration of performance status, it is very important to
make a good assessment of treatment benefit and potential
risks. The main aim of treatment should be palliation and
symptom care.
Conclusion
In this paper we described an unusual hepatocellular
carcinoma metastasis, as bleeding tumor in the maxillary si-
nus spreading to the orbit. In such case, it is quite possible to
overlook the real origin of prolonged bleeding in a patient
with previous intervention on molars. Due to that, it is im-
portant to make a proper diagnosis and find the cause of
every unusual complication, even if they appear after small
interventions.
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